Literature DB >> 11754060

A patient defines the interstitial 1q deletion syndrome characterized by antithrombin III deficiency.

R Pallotta1, L Dalprà, M Miozzo, T Ehresmann, P Fusilli.   

Abstract

A patient with microbrachycephaly, high forehead, long philtrum, thin upper lip, downturned corners of the mouth, low set ears with overlapping helix, fifth-finger clinodactyly, small hands and feet, bilateral transverse palmar crease, low total finger ridge count, hypotonia, severe growth and psychomotor delay, mild hypoplasia of corpus callosum, and Arnold-Chiari type 1 malformation is reported. The karyotype showed 46, XY, del(1)(q23q31.2). Coagulation factor V (F5, 1q23) and coagulation factor XIII (F13B, 1q31-q32.1) levels were normal. As expected, antithrombin III (AT3, 1q23-q25.1) serum level and activity were half of normal. We performed a review of the literature on proximal and intermediate deletion 1q syndrome, and we hypothesize the existence of only one 1q interstitial deletion syndrome, clinically characterized by ATIII deficiency. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11754060     DOI: 10.1002/ajmg.10068

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  3 in total

1.  Microdeletion of chromosome 1q21.3 in fraternal twins is associated with mental retardation, microcephaly, and epilepsy.

Authors:  Fatma Mujgan Sonmez; Eyyup Uctepe; Dilek Aktas; Mehmet Alikasifoglu
Journal:  Intractable Rare Dis Res       Date:  2017-02

2.  Distinctive phenotype in 9 patients with deletion of chromosome 1q24-q25.

Authors:  Deepika D'Cunha Burkardt; Jill A Rosenfeld; Maria L Helgeson; Brad Angle; Valerie Banks; Wendy E Smith; Karen W Gripp; Jessica Moline; Rocio T Moran; Dmitriy M Niyazov; Cathy A Stevens; Elaine Zackai; Robert Roger Lebel; Douglas G Ashley; Nancy Kramer; Ralph S Lachman; John M Graham
Journal:  Am J Med Genet A       Date:  2011-05-05       Impact factor: 2.802

3.  1q25.2-q31.3 Deletion in a female with mental retardation, clinodactyly, minor facial anomalies but no growth retardation.

Authors:  Ping Hu; Yan Wang; Lu-Lu Meng; Ling Qin; Ding-Yuan Ma; Long Yi; Zheng-Feng Xu
Journal:  Mol Cytogenet       Date:  2013-08-06       Impact factor: 2.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.